HEADER HYDROLASE/HYDROLASE INHIBITOR 02-OCT-12 4HDF TITLE CRYSTAL STRUCTURE OF HIV-1 PROTEASE MUTANTS V82A COMPLEXED WITH TITLE 2 INHIBITOR GRL-0519 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HIV-1 PROTEASE; COMPND 3 CHAIN: B, A; COMPND 4 FRAGMENT: UNP RESIDUES 501-599; COMPND 5 SYNONYM: PR, RETROPEPSIN; COMPND 6 EC: 3.4.23.16; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1; SOURCE 3 ORGANISM_COMMON: HIV-1; SOURCE 4 ORGANISM_TAXID: 11686; SOURCE 5 STRAIN: BRU/LAI; SOURCE 6 GENE: GAG-POL; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PET11A KEYWDS ASPARTIC ACID PROTEASE, DRUG RESISTANCE, HIV-1 PROTEASE INHIBITOR KEYWDS 2 GRL-0519, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR H.ZHANG,Y.-F.WANG,I.T.WEBER REVDAT 2 20-SEP-23 4HDF 1 REMARK SEQADV REVDAT 1 14-AUG-13 4HDF 0 JRNL AUTH H.ZHANG,Y.F.WANG,C.H.SHEN,J.AGNISWAMY,K.V.RAO,C.X.XU, JRNL AUTH 2 A.K.GHOSH,R.W.HARRISON,I.T.WEBER JRNL TITL NOVEL P2 TRIS-TETRAHYDROFURAN GROUP IN ANTIVIRAL COMPOUND 1 JRNL TITL 2 (GRL-0519) FILLS THE S2 BINDING POCKET OF SELECTED MUTANTS JRNL TITL 3 OF HIV-1 PROTEASE. JRNL REF J.MED.CHEM. V. 56 1074 2013 JRNL REFN ISSN 0022-2623 JRNL PMID 23298236 JRNL DOI 10.1021/JM301519Z REMARK 2 REMARK 2 RESOLUTION. 1.29 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.29 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.163 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.209 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 2942 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 58831 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : NULL REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.144 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.190 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 2400 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 47476 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1508 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 43 REMARK 3 SOLVENT ATOMS : 180 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 1727.0 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 1633.0 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 21 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 16919 REMARK 3 NUMBER OF RESTRAINTS : 22676 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.012 REMARK 3 ANGLE DISTANCES (A) : 0.031 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.031 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.066 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.068 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.050 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.004 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.052 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.091 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: ANISOTROPIC REFINEMENT REDUCED FREE R REMARK 3 (NO CUTOFF) BY ? REMARK 4 REMARK 4 4HDF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-OCT-12. REMARK 100 THE DEPOSITION ID IS D_1000075326. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-AUG-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 59015 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.290 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.29 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.34 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.7 REMARK 200 DATA REDUNDANCY IN SHELL : 2.50 REMARK 200 R MERGE FOR SHELL (I) : 0.40700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2IDW REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.94 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.73 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10% AMMONIUM SULFATE, 0.05M CITRATE REMARK 280 -PHOSPHATE, PH 5.6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 29.30650 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.07400 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.30650 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.07400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4000 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9640 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -23.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 CL CL B 101 LIES ON A SPECIAL POSITION. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLY B 48 O - C - N ANGL. DEV. = 12.3 DEGREES REMARK 500 GLY B 49 C - N - CA ANGL. DEV. = -13.5 DEGREES REMARK 500 ARG B 57 CD - NE - CZ ANGL. DEV. = 19.6 DEGREES REMARK 500 ARG A 41 O - C - N ANGL. DEV. = -9.7 DEGREES REMARK 500 TRP A 42 C - N - CA ANGL. DEV. = 17.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE G52 A 401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3OK9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 PROTEASE WITH INHIBITOR GRL- REMARK 900 0519 REMARK 900 RELATED ID: 4HDB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 PROTEASE MUTANTS D30N COMPLEXED WITH REMARK 900 INHIBITOR GRL-0519 REMARK 900 RELATED ID: 4HEG RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 PROTEASE MUTANTS R8Q COMPLEXED WITH REMARK 900 INHIBITOR GRL-0519 REMARK 900 RELATED ID: 4HDP RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 PROTEASE MUTANTS I50V COMPLEXED WITH REMARK 900 INHIBITOR GRL-0519 REMARK 900 RELATED ID: 4HE9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 PROTEASE MUTANTS I54M COMPLEXED WITH REMARK 900 INHIBITOR GRL-0519 DBREF 4HDF B 1 99 UNP P03367 POL_HV1BR 501 599 DBREF 4HDF A 1 99 UNP P03367 POL_HV1BR 501 599 SEQADV 4HDF LYS B 7 UNP P03367 GLN 507 ENGINEERED MUTATION SEQADV 4HDF ILE B 33 UNP P03367 LEU 533 ENGINEERED MUTATION SEQADV 4HDF ILE B 63 UNP P03367 LEU 563 ENGINEERED MUTATION SEQADV 4HDF ALA B 67 UNP P03367 CYS 567 ENGINEERED MUTATION SEQADV 4HDF ALA B 82 UNP P03367 VAL 582 ENGINEERED MUTATION SEQADV 4HDF ALA B 95 UNP P03367 CYS 595 ENGINEERED MUTATION SEQADV 4HDF LYS A 7 UNP P03367 GLN 507 ENGINEERED MUTATION SEQADV 4HDF ILE A 33 UNP P03367 LEU 533 ENGINEERED MUTATION SEQADV 4HDF ILE A 63 UNP P03367 LEU 563 ENGINEERED MUTATION SEQADV 4HDF ALA A 67 UNP P03367 CYS 567 ENGINEERED MUTATION SEQADV 4HDF ALA A 82 UNP P03367 VAL 582 ENGINEERED MUTATION SEQADV 4HDF ALA A 95 UNP P03367 CYS 595 ENGINEERED MUTATION SEQRES 1 B 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 B 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 B 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU PRO SEQRES 4 B 99 GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY SEQRES 5 B 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU SEQRES 6 B 99 ILE ALA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 B 99 PRO THR PRO ALA ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 B 99 GLN ILE GLY ALA THR LEU ASN PHE SEQRES 1 A 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 A 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 A 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU PRO SEQRES 4 A 99 GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY SEQRES 5 A 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU SEQRES 6 A 99 ILE ALA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 A 99 PRO THR PRO ALA ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 A 99 GLN ILE GLY ALA THR LEU ASN PHE HET CL B 101 1 HET G52 A 401 84 HETNAM CL CHLORIDE ION HETNAM G52 (3R,3AS,3BR,6AS,7AS)-OCTAHYDRODIFURO[2,3-B:3',2'- HETNAM 2 G52 D]FURAN-3-YL [(1S,2R)-1-BENZYL-2-HYDROXY-3-{[(4- HETNAM 3 G52 METHOXYPHENYL)SULFONYL](2-METHYLPROPYL) HETNAM 4 G52 AMINO}PROPYL]CARBAMATE FORMUL 3 CL CL 1- FORMUL 4 G52 C30 H40 N2 O9 S FORMUL 5 HOH *180(H2 O) HELIX 1 1 GLY B 86 THR B 91 1 6 HELIX 2 2 GLY A 86 THR A 91 1 6 SHEET 1 A 4 GLN B 2 ILE B 3 0 SHEET 2 A 4 THR A 96 ASN A 98 -1 O LEU A 97 N ILE B 3 SHEET 3 A 4 THR B 96 ASN B 98 -1 N ASN B 98 O THR A 96 SHEET 4 A 4 GLN A 2 ILE A 3 -1 O ILE A 3 N LEU B 97 SHEET 1 B 8 LYS B 43 GLY B 49 0 SHEET 2 B 8 GLY B 52 ILE B 66 -1 O GLN B 58 N LYS B 43 SHEET 3 B 8 HIS B 69 VAL B 77 -1 O HIS B 69 N ILE B 66 SHEET 4 B 8 VAL B 32 ILE B 33 1 N ILE B 33 O LEU B 76 SHEET 5 B 8 ILE B 84 ILE B 85 -1 O ILE B 84 N VAL B 32 SHEET 6 B 8 GLN B 18 LEU B 24 1 N LEU B 23 O ILE B 85 SHEET 7 B 8 LEU B 10 ILE B 15 -1 N ILE B 13 O LYS B 20 SHEET 8 B 8 GLY B 52 ILE B 66 -1 O GLU B 65 N LYS B 14 SHEET 1 C 8 LYS A 43 ILE A 47 0 SHEET 2 C 8 ILE A 54 ILE A 66 -1 O GLN A 58 N LYS A 43 SHEET 3 C 8 HIS A 69 VAL A 77 -1 O HIS A 69 N ILE A 66 SHEET 4 C 8 VAL A 32 ILE A 33 1 N ILE A 33 O LEU A 76 SHEET 5 C 8 ILE A 84 ILE A 85 -1 O ILE A 84 N VAL A 32 SHEET 6 C 8 GLN A 18 LEU A 24 1 N LEU A 23 O ILE A 85 SHEET 7 C 8 LEU A 10 ILE A 15 -1 N ILE A 13 O LYS A 20 SHEET 8 C 8 ILE A 54 ILE A 66 -1 O GLU A 65 N LYS A 14 SITE 1 AC1 26 ARG A 8 ASP A 25 GLY A 27 ALA A 28 SITE 2 AC1 26 ASP A 29 ASP A 30 GLY A 48 GLY A 49 SITE 3 AC1 26 ILE A 50 ILE A 84 HOH A 519 HOH A 563 SITE 4 AC1 26 HOH A 565 HOH A 587 ARG B 8 LEU B 23 SITE 5 AC1 26 ASP B 25 GLY B 27 ALA B 28 ASP B 29 SITE 6 AC1 26 ASP B 30 GLY B 48 GLY B 49 ILE B 50 SITE 7 AC1 26 ALA B 82 ILE B 84 CRYST1 58.613 86.148 46.333 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017061 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011608 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021583 0.00000